Scottish Health Innovations Limited (SHIL) partners with NHS Scotland to identify, protect, develop, and commercialize health care innovations, with objectives to transform patient care, generate commercial returns, and stimulate economic wealth. SHIL supports health tech startups in scaling efficiently and advancing innovations such as robotic surgery and telehealth, essential for improving health care outcomes while reducing costs. Established in 2002, SHIL has successfully collaborated with various health boards and showcases innovations like the Scram Bag and Aurum Biosciences.

1. Scottish Health Innovations Limited
(‘SHIL’)
The Health Care Innovation Catalyst
Graham Watson
Executive Chairman
SHIL

2. • SHIL, which is funded by the Chief Scientist Office, works
in partnership with NHS Scotland to identify, protect,
develop and commercialise innovations involving health
care professionals.
• SHIL offers a systematic innovation pathway, as the only
organisation set up to work alongside NHS Scotland on
commercialisation activity. SHIL has been doing this with
every Health Board in Scotland since 2002.
• SHIL has three objectives: help transform patient care;
drive commercial return to NHS Boards and inventors;
stimulate economic wealth.
The Health Care Innovation Catalyst

3. • What is ‘Innovation’?
• Any combination of activities or technologies that break
existing performance tradeoffs in the attainment of an
outcome, in a manner that expands the realm of the
possible.
• Defined in health care as providing “more for less”—
more value, better outcomes, greater convenience,
access and simplicity; all for less cost, complexity, and
time required by the patient and the provider, in a way
that expands what is currently possible.
The Health Care Innovation Catalyst

4. • Globally, health care is an industry in need of
innovation.
• Global health care expenditures are projected to reach
$8.7 trillion by 2020, from $7 trillion in 2015. (Source:
Deloitte)
• Governments, health plans, providers, and life sciences
companies are facing rising costs and inconsistent
outcomes in their pursuit of the triple aim—improving
care, improving health and reducing spending.
The Health Care Innovation Catalyst

5. • In a rapidly changing health care landscape, startups
are playing a pivotal role in reshaping how patients
interact with the health industry.
• It is more important than ever to scale health tech
startups efficiently and build sustainable
relationships with the stakeholders that power the
existing system.
• SHIL provides a framework for startups to grow
rapidly, vet ideas quickly, and interface with top health
care decision makers.
The Health Care Innovation Catalyst

6. • Advancing innovation is a clinical and cost imperative.
• Already, robotic surgery, 3D printing, implantable
devices, and other digital and technology enabled
innovations that target prevention, monitoring, and
treatment, are showing potential to improve outcomes
and reduce costs.
• In addition, new R&D approaches, and big data and
analytics use are creating opportunities for innovation.
The Health Care Innovation Catalyst

7. What are the innovations most likely to transform health
care in the next few years?
The Health Care Innovation Catalyst
Next-generation sequencing Virtual reality
3D-printed devices Social media
Immunotherapy Biosensors and trackers
Artificial intelligence Convenient care
Point-of-care diagnostics Telehealth

8. • Investors see huge potential opportunities from health
care – venture capital funding in the USA has more
than doubled in the past five years from less than $8
billion in 2010 to more than $16 billion in 2015.
"The health care industry continues to be one of the
biggest opportunities for entrepreneurs and investors.”
Dr Bob Kocher, Partner, Venrock
The Health Care Innovation Catalyst

9. • SHIL is interested in looking at innovative ideas of all
kinds.
• Past successes demonstrate the range of SHIL’s
interests and the help that can be provided to
innovators.
• For example, the SCRAM Bag and AURUM Biosciences
Limited.
The Health Care Innovation Catalyst

10. The Health Care Innovation Catalyst
SCRAM BAG
Paul Swinton, Air Ambulance
paramedic with the Scottish
Ambulance Service is co-inventor
of the SCRAM bag - an Emergency
Airway Bag which provides a
structured approach to airway
management. Bringing the idea to
SHIL in 2013, it is now a
commercially available product.

11. The Health Care Innovation Catalyst
A 2015 spin-out company of SHIL, NHS Greater Glasgow
and Clyde and the University of Glasgow, developing novel
pharmaceuticals for use in a number of different clinical
indications of high unmet medical need.

12. • SHIL is headquartered at the Golden Jubilee National
Hospital, Clydebank with satellite offices at Aberdeen
Royal Infirmary (NHS Grampian) and Ninewells Hospital
(NHS Tayside).
• For further information, please contact:
Fiona.fleming@shil.co.uk
0141 951 5506 / 07739013064
Visit SHIL at stand 75 for more information
and a range of useful resources
The Health Care Innovation Catalyst